share_log

Lake Street Maintains Buy on AVITA Medical, Lowers Price Target to $14

Benzinga ·  Jan 9 01:49  · Ratings

Lake Street analyst Brooks O'Neil maintains AVITA Medical (NASDAQ:RCEL) with a Buy and lowers the price target from $20 to $14.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment